Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia

JAMA

Volumn 281, Issue 23, 1999, Pages 2217-2224

  Mak, Victor ^a,c   Zielenski, Julian ^b   Tsui, Lap Chee ^b,c   Durie, Peter ^b,d   Zini, Armand ^a,c   Martin, Sheelagh ^a,b   Longley, Teresa Barry ^a   Jarvi, Keith A ^a,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HETERODUPLEX; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AGENESIS; ALLELE; ARTICLE; AZOOSPERMIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA SEQUENCE; EPIDIDYMIS; EXON; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; VAS DEFERENS;

EID: 0033575077     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.23.2217     Document Type: Article

References (78)

1. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 1995: 3799-3876.
2. Zielenski J, Tsui L-C. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet. 1995;29: 777-807.
3. Kaplan E, Shwachman H, Perlmutter AD, Rule A, Khaw KT, Holsclaw DS. Reproductive failure in males with cystic fibrosis. N Engl J Med. 1968;279:65-69.
4. Valman HB, France NE. The vas deferens in cystic fibrosis. Lancet. 1969;2:566-567.
5. Landing BH, Wells TR, Wang C-I. Abnormality of the epididymis and vas deferens in cystic fibrosis. Arch Pathol. 1969;88:569-580.
6. Taussig LM, Lobeck CC, di Sant'Agnese PA, Ackerman DR, Kattwinkel J. Fertility in males with cystic fibrosis. N Engl J Med. 1972;287:586-589.
7. Anguiano A, Oates RD, Amos JA, et al. Congenital bilateral absence of the vas deferens: a primarily genital form of cystic fibrosis. JAMA. 1992;267:1794-1797.
8. Patrizio P, Asch RH, Handelin B, Silber SJ. Aetiology of congenital absence of vas deferens: genetic study of three generations. Hum Reprod. 1993;8:215-220.
9. Osborne LR, Lynch M, Middleton PG, et al. Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet. 1993;2:1605-1609.
10. Culard J-F, Desgeorges M, Costa P, et al. Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral aplasia of epididymis or vas deferens. Hum Genet. 1994; 93:467-470.
11. Oates RD, Amos JA. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl. 1994;15:1-8.
12. Mercier B, Verlingue C, Lissens W, et al. Is congenital bilateral absence of vas deferens a primary form of cystic f ibrosis? analyses of the CFTR gene in 67 patients. Am J Hum Genet. 1995;56:272-277.
13. Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995;332: 1475-1480.
14. Zielenski J, Patrizio P, Corey M, et al. CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet. 1995;57:958-960.
15. Costes B, Girodon E, Ghanem N, et al. Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet. 1995;3:285-293.
16. Casals T, Bassas L, Ruiz-Romero J, et al. Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected. Hum Genet. 1995;95: 205-211.
17. Rave-Harel N, Madgar I, Goshen R, et al. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet. 1995;56:1359-1366.
18. Jezequel P, Dorval I, Fergelot P, et al. Structural analysis of CFTR gene in congenital bilateral absence of vas deferens. Clin Chem. 1995;41:833-835.
19. Mickle J, Milunsky A, Amos JA, Oates RD. Congenital unilateral absence of the vas deferens: a heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene. Hum Reprod. 1995;10:1728-1735.
20. Durieu I, Bey-Omar F, Rollet J, et al. Diagnostic criteria for cystic fibrosis in men with congenital absence of the vas deferens. Medicine. 1995;74:42-47.
21. Jarvi K, Zielenski J, Wilschanski M, et al. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet. 1995;345:1578.
22. Dumur V, Gervais R, Rigot JM, et al. Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype. Hum Genet. 1996;97:7-10.
23. Bienvenu T, Hubert D, Setbon E, Dusser D, Kaplan JC, Beldjord C. A novel missense mutation in exon 16 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified in CBAVD patients. Hum Mutat. 1996;7:182.
24. Bienvenu T, Claustres M. Molecular basis of cystic fibrosis and congenital bilateral agenesis of vas deferens. Contracept Fertil Sex. 1996;24:495-500.
25. Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol. 1996;155:1644-1648.
26. Lissens W, Mercier B, Tournaye H, et al. Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities. Hum Reprod. 1996;11(suppl 4):55-78.
27. Patrizio P, Zielenski J. Congenital absence of the vas deferens: a mild form of cystic fibrosis. Mol Med Today. 1996;2:24-31.
28. Donat R, McNeill AS, Fitzpatrick DR, Hargreave TB. The incidence of cystic fibrosis gene mutations in patients with congenital bilateral absence of the vas deferens in Scotland. Br J Urol. 1997;79:74-77.
29. Bienvenu T, Adjiman M, Thiounn N, et al. Molecular diagnosis of congenital bilateral absence of the vas deferens: analyses of the CFTR gene in 64 French patients. Ann Genet. 1997;40:5-9.
30. Durieu I, Bey-Omar F, Rollet J, et al. Male infertility caused by bilateral agenesis of the vas deferens: a new clinical form of cystic fibrosis? Rev Med Interne. 1997;18:114-118.
31. Shin D, Gilbert F, Goldstein M, Schlegel PN. Congenital absence of the vas deferens: incomplete penetrance of cystic fibrosis gene mutations. J Urol. 1997; 158:1794-1798.
32. Dork T, Dworniczak B, Aulehla-Scholz C, et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997;100:365-377.
33. Kanavakis E, Tzetis M, Antoniadi T, Pistofidis G, Milligos S, Kattamis C. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia. Mol Hum Reprod. 1998;4:333-337.
34. Mak V, Jarvi KA, Zielenski J, Durie P, Tsui L-C. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum Mol Genet. 1997;6:2099-2107.
35. Temple-Smith PD, Southwick GJ, Yates CA, Trounson AO, de Krester DM. Human pregnancy by in vitro fertilization (IVF) using sperm aspirated from the epididymis. J In Vitro Fert Embryo Transf. 1985;2:119-122.
36. Silber SJ, Balmaceda J, Borrero C, Ord T, Asch R. Pregnancy with sperm aspiration from the proximal head of the epididymis: a new treatment for congenital absence of the vas deferens. Fertil Steril. 1988; 50:525-528.
37. Patrizio P, Silber S, Ord T, Balmaceda JP, Asch RH. Two births after microsurgical sperm aspiration in congenital absence of vas deferens. Lancet. 1988;2: 1364.
38. Silber SJ, Ord T, Balmaceda J, Patrizio P, Asch RH. Congenital absence of the vas deferens: the fertilizing capacity of human epididymal sperm. N Engl J Med. 1990;323:1788-1792.
39. Bladou F, Grillo JM, Rossi D, et al. Epididymal sperm aspiration in conjunction with in-vitro fertilization and embryo transfer in cases of obstructive azoospermia. Hum Reprod. 1991;6:1284-1287.
40. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992; 340:17-18.
41. Mathieu C, Guerin JF, Cognat M, Lejeune H, Pinatel MC, Lornage J. Motility and fertilizing capacity of epididymal human spermatozoa in normal and pathological cases. Fertil Steril. 1992;57:871-876.
42. Oates RD, Honig S, Berger MJ, Harris D. Microscopic epididymal sperm aspiration (MESA): a new option for treatment of the obstructive azoospermia associated with cystic fibrosis. J Assist Reprod Genet. 1992;9:36-40.
43. Van Steirteghem AC, Nagy Z, Joris H, et al. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod. 1993;8:1061-1066.
44. Fukugaki H, Suganuma N, Kitagawa T, et al. Successful in vitro fertilization and pregnancy by micromanipulation with epididymal sperm. J Assist Reprod Genet. 1994;11:452-458.
45. Harari O, Bourne H, McDonald M, et al. Intracytoplasmic sperm injection: a major advance in the management of severe male subfertility. Fertil Steril. 1995;64:360-368.
46. Schlegel PN, Palermo GD, Alikani M, et al. Micropuncture retrieval of epididymal sperm with in vitro fertilization: importance of in vitro micromanipulation techniques. Urology. 1995;46:238-241.
47. Son IP, Hong JY, Lee YS. et al. Efficacy of microsurgical epididymal sperm aspiration (MESA) and intracytoplasmic sperm injection (ICSI) in obstructive azoospermia. J Assist Reprod Genet. 1996;13:69-72.
48. Madgar I, Seidman DS, Levran D, et al Micromanipulation improves in-vitro fertilization results after epididymal or testicular sperm aspiration in patients with congenital absence of the vas deferens. Hum Reprod. 1996;11:2151-2154.
49. Cha KY, Oum KB, Kim HJ. Approaches for obtaining sperm in patients with male factor infertility. Fertil Steril. 1997;67:985-995.
50. Mansour RT, Kamal A, Fahmy I, Tawab N, Serour GI, Aboulghar MA. Intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia. Hum Reprod. 1997;12:1974-1979.
51. Handyside AH, Lesko JC, Tarin JJ, Winston RM, Hughes MR. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med. 1992;327:905-909.
52. de Kretser DM. The potential of intracytoplasmic sperm injection (ICSI) to transmit genetic defects causing male infertility. Reprod Fertil Dev. 1995;7: 137-141.
53. Cummins JM, Jequier AM. Concerns and recommendations for intracytoplasmic sperm injection (ICSI) treatment. Hum Reprod. 1995;10(suppl 1):138-143.
54. Mak V, Jarvi KA. The genetics of male infertility. J Urol. 1996;156:1245-1256.
55. Johnson MD. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. Fertil Steril. 1998;70:397-411.
56. Lawler AM, Gearhart JD. Genetic counseling for patients who will be undergoing treatment with assisted reproductive technology. Fertil Steril. 1998;70: 412-413.
57. Jarvi K, McCallum S, Zielenski J, et al. Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations. Fertil Steril. 1998;70:724-728.
58. Census Operations Division. Statistics Canada, 7996 Census Nation: Tables. Ottawa, Ontario: Census Operations Division; 1996.
59. Miller SA, Dykes DD, Polesky MF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
60. Cystic Fibrosis Genetic Analysis Consortium Website. Available at: http://www.genet.sickkids.on.ca/ cftr/. Accessed May 12, 1999.
61. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986;51(pt 1):263-273.
62. Zielenski J, Rozmahel R, Bozon D, et al. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991; 10:214-228.
63. Kiesewetter S, Macek M Jr, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet. 1993;5:274-278.
64. Aznarez I, Onay I, Tzounzouris J, et al. An efficient protocol for CFTR mutation detection based on multiplex heteroduplex analysis (mHET) [abstract]. Pediatr Pulmonol. 1998;17(suppl):332.
65. Cuppens H, Teng H, Raeymaekers P, De Boeck C, Cassiman JJ. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet. 1994; 3:607-614.
66. Dork T, Fislage R, Neumann T, Wulf B, Tummler B. Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations. Hum Genet. 1994;93:67-73.
67. Schoysman R. Epididymal causes of male infertility: pathogenesis and management. Int J Androl. 1982;5(suppl):120-134.
68. Young D. Surgical treatment of male infertility. J Reprod Fertil. 1970;23:541-542.
69. Hendry WF, A'Hem RP, Cole PJ. Was Young's syndrome caused by exposure to mercury in childhood? BMJ. 1993;307:1579-1582.
70. Friedman KJ, Teichtahl H, De Kretser DM, et al. Screening Young syndrome patients for CFTR mutations. Am J Respir Crit Care Med. 1995;152:1353-1357.
71. Meschede D, Horst J, Williams C, Williamson R. Genetic testing and counselling for congenital bilateral absence of the vas deferens. Lancet. 1994;343: 1566-1567.
72. Burger J, Macek M Jr, Stuhrmann M, Reis A, Krawczak M, Schmidtke J. Genetic influences in the formation of nasal polyps. Lancet. 1991;337:974.
73. Pignatti PF, Bombieri C, Marigo C, Benetazzo M, Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet. 1995;4:635-639.
74. Pignatti PF, Bombieri C, Benetazzo M, et al. CFTR gene variant IVS8-5T in disseminated bronchiectasis. Am J Hum Genet. 1996;58:889-892.
75. Miller PW, Hamosh A, Macek M Jr, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet. 1996;59:45-51.
76. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998;339:645-652.
77. Conn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998;339:653-658.
78. National Institutes of Health Consensus Statement. Genetic testing for cystic fibrosis. Available at: http://odp.od.nih.gov/consensus/cons/106/ 106_statement.htm. Accessed May 12, 1999.